Comments on:

Manhattan Moment: Get FDA off the slow track

Back to the article » |
A biomedical revolution is here. Researchers can now target drugs at the molecular roots of diseases. Combined with advances in computing power and predictive analytics, companies and physicians can tailor complex treatment regimens to a patient's unique biology. We're just scratching the surface of what is possible, but early advances verge on the miraculous. Last year, for instance, the...